Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 29 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Recruiting
A Study of ARC-02 in B-cell NHL
NCT07691606
- Conditions
- B-cell Non Hodgkin Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +21 more
- Locations
-
- Start Cala Los Angeles, California, United States
- Norton Cancer Institute Louisville, Kentucky, United States
- NYU Langone New York, United States
- Levine Cancer Institute Charlotte, North Carolina, United States
NCT04544592
- Conditions
- B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma, Burkitt Lymphoma, +20 more
- Locations
-
- Children's Hospital Colorado Aurora, Colorado, United States
NCT05702853
- Conditions
- B-cell Non Hodgkin Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +18 more
- Locations
-
- Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina, United States
NCT05991388
- Conditions
- B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- The Children's Hospital at Westmead Sydney, New South Wales, Australia
- Queensland Children's Hospital Brisbane, Queensland, Australia
- Perth Children's Hospital Perth, Washington, Australia
- St. Anna Children's Hospital Vienna, Austria
NCT06365671
- Conditions
- B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, China
NCT06392477
- Conditions
- B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Investigational Site Number : 001-203 Camperdown, New South Wales, Australia
- Investigational Site Number : 001-202 Townsville, Queensland, Australia
- Investigational Site Number : 001-205 Adelaide, South Australia, Australia
- Investigational Site Number : 001-204 Melbourne, Victoria, Australia
NCT06508775
- Conditions
- Acute Lymphatic Leukemia, B-cell Non Hodgkin Lymphoma, Childhood Non-Hodgkin Lymphoma, +34 more
- Locations
-
- Charité Universitätsmedizin Berlin Berlin, Germany
- Universitätsklinikum Köln Cologne, Germany
- Uniklinikum Erlangen Erlangen, Germany
- Universitätsmedizin Göttingen Göttingen, Germany
NCT06707259
- Conditions
- B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- the Second Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, Zhejiang, China
NCT05472558
- Conditions
- B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hanzhou, Zhejiang, China
NCT06725524
- Conditions
- B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Ruijin Hospital Shanghai, China
NCT05338931
- Conditions
- B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Asan Medical Center Seoul, South Korea
Not Yet Recruiting
Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
NCT07225439
- Conditions
- B-cell Non Hodgkin Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +30 more
- Locations
-
- Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center Cleveland, Ohio, United States
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute Cleveland, Ohio, United States
Not Yet Recruiting
Fully Human Bispecific Anti-CD20, Anti-CD19 CAR T Cells for Patients With Relapsed and/or Refractory B Cell Malignancies
NCT07335328
- Conditions
- B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States
Not Yet Recruiting
Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL
NCT05779930
- Conditions
- Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia, in Relapse, B Cell Leukemia, +22 more
- Locations
-
- Nationwide Children's Hospital Columbus, Ohio, United States
Not Yet Recruiting
ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCT
NCT06646666
- Conditions
- B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Department of Hematology, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, China
NCT05927558
- Conditions
- B-cell Non Hodgkin Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- Ematologia Istituto Nazionale Tumori Milan, Italy
NCT04088890
- Conditions
- B-ALL, B-cell Non Hodgkin Lymphoma, DLBCL, +11 more
- Locations
-
- Stanford Medical Center Stanford, California, United States
NCT01516580
- Conditions
- B-cell Non Hodgkin Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +16 more
- Locations
-
- University Hospitals Leuven Leuven, Belgium
- Children Oncology Group Operations centres Monrovia, Canada
- The University of Hong Kong (Clinical Trials Centre) Hong Kong, China
- Institut de Cancérologie Gustave roussy Villejuif, France
NCT06027957
- Conditions
- B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma, Burkitt Lymphoma, +16 more
- Locations
-
- Vinmec Research Institute of Stem Cell and Gene Technology Hanoi, Vietnam
NCT03870945
- Conditions
- B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Klinikum Augsburg, II. Med. Klinik Haematologie / Onkologie Augsburg, Bavaria, Germany
- University Hospital Cologne - Department for Internal Medicine I Cologne, North Rhine-Westphalia, Germany
- Universitätsklinikum Hamburg-Eppendorf, Department of Stem Cell Transplantation Hamburg, Germany